Breast Cancer Clinical Trial
Physical Activity to Reduce Joint Pain During Aromatase Inhibitor Therapy
Summary
For post-menopausal women diagnosed with hormone-receptor positive breast cancer tumors, aromatase inhibitors (AIs) are the standard adjuvant hormone treatment to prolong disease-free survival and time-to-recurrence. Unfortunately, joint pain/stiffness/achiness (arthralgia) is a common side-effect of AIs. This "proof-of-concept" study explores how an evidence-based physical activity (PA) program- the Arthritis Foundation's Walk with Ease (WWE) program- can be adapted for breast cancer survivors on AI therapy to: 1) Help them maintain or achieve recommended levels of PA, 2) reduce their joint pain/stiffness/achiness, and 3) thereby enable them to remain on AI therapy as prescribed.
Eligibility Criteria
Inclusion Criteria:
Taking an aromatase inhibitor as adjuvant treatment for State I, II, or II breast cancer for at least 4 weeks
Experiencing more than mild joint pain/symptoms
21 or older
have permission from physician to engage in moderate intensity physical activity
Exclusion Criteria:
Undergoing chemotherapy and/or radiation therapy at any time during the study period
Scheduled for major surgery during the study period
Presently engaged in high levels of physical activity on a daily basis
Less than 21 years of age
Unable to walk or engage in moderate intensity physical activity
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Chapel Hill North Carolina, 27599, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.